U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07009171) titled 'Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients' on May 15.
Brief Summary: This is a randomized, double-blind, placebo-controlled, dose-escalation, Phase 2a study designed to evaluate the safety and efficacy of KDS2010 in overweight or obese patients. Based on preliminary efficacy observed in the Phase 1 study, a multinational clinical trial is being conducted in both Korea and the United States. After a minimum 2-week run-in period, subjects who meet the inclusion and exclusion criteria will be randomized into each dose group at a 2:1 ratio in Stage 1 and in a 1:1:1 ratio in Stage 2, considering ...